SG/CALL/CVS HEALTH/90/0.1/20.06.25 Share Price

Warrant

DE000SU6E350

Market Closed - Boerse Frankfurt Warrants 01:16:38 23/05/2024 am IST
0.074 EUR -6.33% Intraday chart for SG/CALL/CVS HEALTH/90/0.1/20.06.25
Current month-57.78%
1 month-66.96%
Date Price Change
22/24/22 0.076 -3.80%
21/24/21 0.079 0.00%
20/24/20 0.079 0.00%
17/24/17 0.079 -3.66%
16/24/16 0.082 +17.14%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 01:16 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SU6E35
ISINDE000SU6E350
Date issued 29/12/2023
Strike 90 $
Maturity 20/06/2025 (394 Days)
Parity 10 : 1
Emission price 0.56
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.69
Lowest since issue 0.057
Spread 0.01
Spread %11.76%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.44 USD
Average target price
71.37 USD
Spread / Average Target
+24.26%
Consensus